WuXi Biologics (Cayman) Inc. (FRA:1FW1)
Germany · Delayed Price · Currency is EUR 6.80
+0.05 (0.74%)
At close: Nov 28, 2025
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of €14.43 billion as of December 2, 2025. Its market cap has increased by 71.23% in one year.
Market Cap
14.43B
Enterprise Value
14.02B
Revenue
2.38B
Ranking
n/a
PE Ratio
28.92
Stock Price
€6.80
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 3.67B to 14.43B, an increase of 293.60%. That is a compound annual growth rate of 17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 14.43B | 60.90% |
| Dec 31, 2024 | 8.97B | -38.06% |
| Dec 29, 2023 | 14.48B | -52.26% |
| Dec 30, 2022 | 30.32B | -31.22% |
| Dec 31, 2021 | 44.08B | -0.43% |
| Dec 31, 2020 | 44.28B | 203.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |